LGMN and central nervous system cancer: In the examination of the normal tissues and a variety of tumor tissue, legumain had a low expression in normal tissue; the high expression was detected in many solid tumors, including breast, colon, lung, prostate, and ovarian tumors and malignant tumors of the central nervous system (34–37).